The effects of immunosuppressants on vascular function, systemic oxidative stress and inflammation in rats

Transplant International

Volumn 25, Issue 3, 2012, Pages 337-346

  Shing, Cecilia M ^a   Fassett, Robert G ^b,c   Brown, Lindsay ^c   Coombes, Jeff S ^c  

^a UNIVERSITY OF TASMANIA   (Australia)

^b ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^c UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

cyclosporine A; everolimus; F2 isoprostanes; sirolimus; tacrolimus; vascular function

Indexed keywords

ACETYLCHOLINE; CALCINEURIN INHIBITOR; CATALASE; CYCLOSPORIN A; EVEROLIMUS; GLUTATHIONE PEROXIDASE; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 1BETA; ISOPROSTANE DERIVATIVE; MALONALDEHYDE; MAMMALIAN TARGET OF RAPAMYCIN INHIBITOR; NITROPRUSSIDE SODIUM; NORADRENALIN; PLACEBO; RAPAMYCIN; SUPEROXIDE DISMUTASE; TACROLIMUS; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD VESSEL REACTIVITY; CARDIOVASCULAR RISK; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG BLOOD LEVEL; DRUG MEGADOSE; ENDOTHELIAL DYSFUNCTION; GLOMERULUS FILTRATION; INFLAMMATION; LIPID PEROXIDATION; LOW DRUG DOSE; MALE; NONHUMAN; ORGAN TRANSPLANTATION; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; SMOOTH MUSCLE CONTRACTION; VASCULAR ENDOTHELIUM; WISTAR RAT;

ANIMALS; AORTA; BIOLOGICAL MARKERS; CYCLOSPORINE; CYTOKINES; ENDOTHELIUM, VASCULAR; IMMUNOSUPPRESSIVE AGENTS; INFLAMMATION; MALE; MUSCLE, SMOOTH; OXIDATIVE STRESS; RATS; RATS, WISTAR; SIROLIMUS; TACROLIMUS;

EID: 84857041021     PISSN: 09340874     EISSN: 14322277     Source Type: Journal    
DOI: 10.1111/j.1432-2277.2011.01420.x     Document Type: Article

References (52)

1. Howard RJ, Patton PR, Reed AI, et al. The changing causes of graft loss and death after kidney transplantation. Transplantation 2002; 73: 1923.
2. Zhang R, Kumar P, Ramcharan T, Reisin E,. Kidney transplantation: the evolving challenges. Am J Med Sci 2004; 328: 156.
3. Gotlieb AI,. Smooth muscle and endothelial cell function in the pathogenesis of atherosclerosis. Can Med Assoc J 1982; 126: 903.
4. Rudijanto A,. The role of vascular smooth muscle cells on the pathogenesis of atherosclerosis. Acta Med Indones 2007; 39: 86.
5. Aliabadi AZ, Pohanka E, Seebacher G, et al. Development of proteinuria after switch to sirolimus-based immunosuppression in long-term cardiac transplant patients. Am J Transplant 2008; 8: 854.
6. Boratynska M, Banasik M, Watorek E, et al. Conversion to sirolimus from cyclosporine may induce nephrotic proteinuria and progressive deterioration of renal function in chronic allograft nephropathy patients. Transplant Proc 2006; 38: 101.
7. Sabry AA, Elagroudy AE, El-dahshan KF, El-Rahim MA, Sobh MA,. Is sirolimus a nephrotoxic drug? A report of five cases Transplant Proc 2007; 39: 1406.
8. Galletti P, Di Gennaro CI, Migliardi V, et al. Diverse effects of natural antioxidants on cyclosporin cytotoxicity in rat renal tubular cells. Nephrol Dial Transplant 2005; 20: 1551.
9. Lexis LA, Fenning A, Brown L, Fassett RG, Coombes JS,. Antioxidant supplementation enhances erythrocyte antioxidant status and attenuates cyclosporine-induced vascular dysfunction. Am J Transplant 2006; 6: 41.
10. Prabhakar U, Eirikis E, Reddy M, et al. Validation and comparative analysis of a multiplexed assay for the simultaneous quantitative measurement of Th1/Th2 cytokines in human serum and human peripheral blood mononuclear cell culture supernatants. J Immunol Methods 2004; 2: 27.
11. DiJoseph JF, Fluhler E, Armstrong J, Sharr M, Sehgal SN,. Therapeutic blood levels of sirolimus (rapamycin) in the allografted rat. Transplantation 1996; 62: 1109.
12. Rizell M, Lindner P,. Inhibition of mTOR suppresses experimental liver tumours. Anticancer Res 2005; 25: 789.
13. Ikezumi Y, Kanno K, Koike H, et al. FK506 ameliorates proteinuria and glomerular lesions induced by anti-Thy 1.1 monoclonal antibody 1-22-3. Kidney Int 2002; 61: 1339.
14. Nielsen FT, Starklint H, Dieperink H,. Impaired glomerular and tubular function as a short-term effect of sirolimus treatment in the rat. Am J Nephrol 2005; 25: 411.
15. Napoli KL, Wang ME, Stepkowski SM, Kahan BD,. Distribution of sirolimus in rat tissue. Clin Biochem 1997; 30: 135.
16. Granger DK, Cromwell JW, Chen SC, et al. Prolongation of renal allograft survival in a large animal model by oral rapamycin monotherapy. Transplantation 1995; 59: 183.
17. Lexis LA, Richards RS, Fassett RG, Coombes JS,. Cyclosporine A-induced changes to erythrocyte redox balance is time course-dependent. Basic Clin Pharmacol Toxicol 2005; 97: 135.
18. Schmitz V, Klawitter J, Bendrick-Peart J, et al. Metabolic profiles in urine reflect nephrotoxicity of sirolimus and cyclosporine following rat kidney transplantation. Nephron Exp Nephrol 2009; 111: e80.
19. Taylor AW, Bruno RS, Frei B, Traber MG,. Benefits of prolonged gradient separation for high-performance liquid chromatography-tandem mass spectrometry quantitation of plasma total 15-series F-isoprostanes. Anal Biochem 2006; 350: 41.
20. Mori TA, Croft KD, Puddey IB, Beilin LJ,. An improved method for the measurement of urinary and plasma F2-isoprostanes using gas chromatography-mass spectrometry. Anal Biochem 1999; 268: 117.
21. Sim AS, Salonikas C, Naidoo D, Wilcken DE,. Improved method for plasma malondialdehyde measurement by high-performance liquid chromatography using methyl malondialdehyde as an internal standard. J Chromatogr B Analyt Technol Biomed Life Sci 2003; 785: 337.
22. Wheeler CR, Salzman JA, Elsayed NM, Omaye ST, Korte Jr DW,. Automated assays for superoxide dismutase, catalase, glutathione peroxidase, and glutathione reductase activity. Anal Biochem 1990; 184: 193.
23. Madesh M, Balasubramanian KA,. Microtiter plate assay for superoxide dismutase using MTT reduction by superoxide. Indian J Biochem Biophys 1998; 35: 184.
24. Slaughter MR, O'Brien PJ,. Fully-automated spectrophotometric method for measurement of antioxidant activity of catalase. Clin Biochem 2000; 33: 525.
25. Miller NJ, Rice-Evans C, Davies MJ, Gopinathan V, Milner A,. A novel method for measuring antioxidant capacity and its application to monitoring the antioxidant status in premature neonates. Clin Sci (Lond) 1993; 84: 407.
26. Laurent S, Boutouyrie P, Asmar R, et al. Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension 2001; 37: 1236.
27. Levy AS, Chung JC, Kroetsch JT, Rush JW,. Nitric oxide and coronary vascular endothelium adaptations in hypertension. Vasc Health Risk Manag 2009; 5: 1075.
28. Gao YJ, Lee RM,. Hydrogen peroxide is an endothelium-dependent contracting factor in rat renal artery. Br J Pharmacol 2005; 146: 1061.
29. Jabs A, Gobel S, Wenzel P, et al. Sirolimus-induced vascular dysfunction Increased mitochondrial and nicotinamide adenosine dinucleotide phosphate oxidase-dependent superoxide production and decreased vascular nitric oxide formation. J Am Coll Cardiol 2008; 51: 2130.
30. Jardine AG,. Assessing the relative risk of cardiovascular disease among renal transplant patients receiving tacrolimus or cyclosporine. Transpl Int 2005; 18: 379.
31. Seibert F, Behrendt C, Schmidt S, Van der Giet M, Zidek W, Westhoff TH,. Differential effects of cyclosporine and tacrolimus on arterial function. Transpl Int 2011; 24: 708.
32. Oriji GK, Keiser HR,. Nitric oxide in cyclosporine A-induced hypertension: role of protein kinase C. Am J Hypertens 1999; 1: 1091.
33. Can C, Erol A, Cinar M, Olukman M, Ulker S, Evinc A,. Therapeutic concentrations of tacrolimus do not interfere with endothelial nitric oxide synthesis in rat thoracic aortas and coronary arteries. J Cardiovasc Pharmacol 2007; 50: 399.
34. Ulu N, Schoemaker RG, Henning RH, et al. Proteinuria-associated endothelial dysfunction is strain dependent. Am J Nephrol 2009; 30: 209.
35. Johannesen J, Pociot F, Karlsen AE, Mandrup-Poulsen T, Nerup J,. Strain-dependent difference in inducible nitric oxide synthesis (iNOS) expression in rat pancreatic islets correlates with interferon regulating factor 1 (IRF-1) and heat shock protein 70 (HSP70) expression. Eur Cytokine Netw 2001; 12: 501.
36. Takeda Y, Miyamori I, Furukawa K, Inaba S, Mabuchi H,. Mechanisms of FK 506-induced hypertension in the rat. Hypertension 1999; 33: 130.
37. Oflaz H, Turkmen A, Kazancioglu R, et al. The effect of calcineurin inhibitors on endothelial function in renal transplant recipients. Clin Transplant 2003; 17: 212.
38. Cook LG, Chiasson VL, Long C, Wu GY, Mitchell BM,. Tacrolimus reduces nitric oxide synthase function by binding to FKBP rather than by its calcineurin effect. Kidney Int 2009; 75: 719.
39. Marumo T, Nakaki T, Hishikawa K, Suzuki H, Kato R, Saruta T,. Cyclosporin A inhibits nitric oxide synthase induction in vascular smooth muscle cells. Hypertension 1995; 2: 764.
40. Rego A, Vargas R, Wroblewska B, Foegh ML, Ramwell PW,. Attenuation of vascular relaxation and cyclic GMP responses by cyclosporin A. J Pharmacol Exp Ther 1990; 252: 165.
41. Kirchner GI, Meier-Wiedenbach I, Manns MP,. Clinical pharmacokinetics of everolimus. Clin Pharmacokinet 2004; 43: 83.
42. Tenderich G, Fuchs U, Zittermann A, Muckelbauer R, Berthold HK, Koerfer R,. Comparison of sirolimus and everolimus in their effects on blood lipid profiles and haematological parameters in heart transplant recipients. Clin Transplant 2007; 21: 536.
43. Raber L, Juni P, Nuesch E, et al. Long-term comparison of everolimus-eluting and sirolimus-eluting stents for coronary revascularization. J Am Coll Cardiol 2011; 57: 2143.
44. Serkova N, Jacobsen W, Niemann CU, et al. Sirolimus, but not the structurally related RAD (everolimus), enhances the negative effects of cyclosporine on mitochondrial metabolism in the rat brain. Br J Pharmacol 2001; 133: 875.
45. Bonaventura D, Lunardi CN, Rodrigues GJ, Neto MA, Bendhack LM,. A novel mechanism of vascular relaxation induced by sodium nitroprusside in the isolated rat aorta. Nitric Oxide 2008; 18: 287.
46. Ghatta S, Tunstall RR, Kareem S, Rahman M, O'Rourke ST,. Sirolimus causes relaxation of human vascular smooth muscle: a novel action of sirolimus mediated via ATP-sensitive potassium channels. J Pharmacol Exp Ther 2007; 320: 1204.
47. Ma KL, Ruan XZ, Powis SH, Moorhead JF, Varghese Z,. Anti-atherosclerotic effects of sirolimus on human vascular smooth muscle cells. Am J Physiol Heart Circ Physiol 2007; 292: H2721.
48. Reyes-Toso CF, Linares LM, Witriw A, Vazquez MB, Ricci CR, Cardinali DP,. Antioxidants restore aortic ring relaxation in pancreatectomized rats. Life Sci 2007; 20: 1467.
49. Naesens M, Kuypers DR, Sarwal M,. Calcineurin inhibitor nephrotoxicity. Clin J Am Soc Nephrol 2009; 4: 481.
50. Klawitter J, Bendrick-Peart J, Rudolph B, et al. Urine metabolites reflect time-dependent effects of cyclosporine and sirolimus on rat kidney function. Chem Res Toxicol 2009; 22: 118.
51. Ilbey YO, Ozbek E, Cekmen M, et al. Melatonin prevents acetaminophen-induced nephrotoxicity in rats. Int Urol Nephrol 2009; 41: 695.
52. Holdaas H, Midtvedt K, Seron D, et al. Everolimus in maintenance renal transplant recipients: the ASCERTAIN Study. Transpl Int 2009; 22: 172.